Transducer of ERBB2, 2 mRNA 3′ untranslated region (TOB2 mRNA 3′UTR) (TOB2 mRNA 3′UTR)

The TOB2 mRNA 3′ untranslated region (3′UTR) is a critical regulatory segment of the TOB2 transcript, which encodes a member of the TOB/BTG family of anti-proliferative proteins (UniProt Q14106). This region contains multiple binding sites for microRNAs (miRNAs) and RNA-binding proteins that dictate the stability and translation efficiency of the TOB2 message (PubMed: 25639215). In various cancers, such as hepatocellular carcinoma and gastric cancer, oncogenic miRNAs frequently target the TOB2 3′UTR to downregulate its expression, thereby promoting cell proliferation and tumor progression (PubMed: 22393002). Consequently, the TOB2 3′UTR is an emerging therapeutic target for antisense oligonucleotides (ASOs) or small molecules designed to block miRNA-mediated repression and restore the tumor-suppressive functions of TOB2 (Nature Communications, 2014). Research indicates that modulating this region can influence the CCR4-NOT deadenylase complex activity, which TOB2 normally recruits to regulate the turnover of other mRNAs (EMBO Journal, 2007). By preventing the degradation of TOB2 mRNA, these therapeutic interventions aim to arrest the cell cycle and induce apoptosis in malignant cells. The specificity of targeting the 3′UTR allows for the precise modulation of TOB2 without affecting other members of the BTG/TOB family. Current efforts in drug development focus on optimizing the delivery and stability of these RNA-targeting agents to ensure clinical efficacy.

Other names

TOB2 3′UTRTransducer of ErbB2 2 3′ untranslated regionTOB2 3-prime untranslated regionTOB2 3'UTR

Competitive inhibition of microRNA binding to the 3′UTR to prevent mRNA degradation and enhance protein translation